Reducing kidney and heart risk in diabetes with targeted therapy
Treatments studied
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a personalized medication approach to lower kidney and heart risks in people with type 2 diabetes and early-to-moderate kidney disease. It may help you if you have a high chance of heart problems and can start new medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 2 diabetes.
- You have kidney disease (estimated GFR between 25-60 or increased protein in your urine).
- You have high risk for heart problems (like a past heart attack, stroke, or certain risk factors like high cholesterol, high blood pressure, or atrial fibrillation if you are 40 or older).
- You are willing to start new medications.
- You are not already on three or more of these medication types: ACE/ARB, SGLT2i, nsMRA, or GLP1 receptor agonists.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help primary care doctors better screen and manage kidney problems in people with type 2 diabetes. It aims to see if using recommended medicines can slow kidney disease and improve health.
This study tests new treatments to protect the heart and kidneys in people with long-standing type 1 diabetes. It aims to prevent or slow down complications like heart failure and kidney damage.
This study tests whether diabetes medicines can help prevent worsening heart and kidney problems in people with type 2 diabetes. You’ll be assigned by chance to one of these medicine types, and your other care will be adjusted for safety.
This trial tests whether a new drug, HTD1801, can protect or improve kidney function in people with type 2 diabetes and chronic kidney disease. It may help slow kidney damage and reduce protein in urine.
This study tests a new care approach for people with diabetes who have early-to-moderate kidney disease. The goal is to help prevent serious kidney and heart problems by improving how care is coordinated.
This Phase 4 trial studies an approach to help prevent heart problems in adults with type 2 diabetes who are at higher heart risk. It may help reduce future cardiovascular events by testing medications for safety and benefit in this group.
Hear when a new Diabetic Kidney Disease (DKD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.